Finding the origins of cancer with Rosetta Genomics
Taking its name from the Rosetta Stone, which paved the way to decipher ancient Egyptian hieroglyphics, Rosetta Genomics (NASDAQ:ROSG) is unlocking the relevance of microRNA within the human genome to...
View ArticleRosetta Genomics in pact for thyroid cancer diagnostic
Rosetta Genomics (NASDAQ:ROSG) has initiated a new public-private translational research project with the Institute of Molecular Translational Medicine (IMTM) at Palacky University, Olomouc, Czech...
View ArticleCantor upgrades Rosetta Genomics to buy
Cantor Fitzgerald has upgraded Rosetta Genomics (NASDAQ:ROSG) to “buy” from “hold” and raised its price target to $5.50 from $4, following the company’s acquisition of PersonalizeDx (PDx) from Abbott....
View Article
More Pages to Explore .....